Acelyrin says CRO Fortrea made errors in trial of lead immunology drug izokibep
Acelyrin said a contract research organization conducting studies of its lead experimental drug had made “clinical trial execution errors” and it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
